Abstract
Neuromuscular blocking agents (NMBAs) are typically used to facilitate tracheal intubation and mechanical ventilation and provide appropriate conditions for surgery. Prompt reversal of neuromuscular blockage is desired in some situations. Until recently, acetylcholinesterase inhibitors such as neostigmine were the only reversal agents available. These agents are often associated with bradycardia, bronchospasm, and other side effects because of their muscarinic activity. Anticholinergic agents used to relieve these muscarinic side effects are themselves associated with other unacceptable side effects. Russell D. MacDonald, MD, MPH, FCFP, FRCPC, is the medical director at Ornge Transport Medicine; medical director at Toronto Paramedic Services; an associate professor in the Faculty of Medicine at the University of Toronto; and an attending staff member at Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada. He can be reached at .
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.